- Q2 2024 Neogenomics Inc Earnings Call TranscriptJul 29, 2024$14.64 (-1.61%)Earnings
- Q1 2024 Neogenomics Inc Earnings Call TranscriptApr 30, 2024$13.92 (-8.54%)Earnings
- Q4 2023 Neogenomics Inc Earnings Call TranscriptFeb 20, 2024$14.7 (+2.37%)Earnings
- Neogenomics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 Neogenomics Inc Earnings Call TranscriptNov 06, 2023$14.65 (-4.06%)Earnings
- Q2 2023 Neogenomics Inc Earnings Call TranscriptAug 08, 2023$15.32 (-3.04%)Earnings
- Neogenomics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Neogenomics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Neogenomics Inc Earnings Call TranscriptMay 08, 2023$15.4 (+0.59%)Earnings
- Neogenomics Inc Investor Day TranscriptApr 04, 2023
- Q4 2022 Neogenomics Inc Earnings Call TranscriptFeb 23, 2023$16.63 (+24.57%)Earnings
- Q3 2022 Neogenomics Inc Earnings Call TranscriptNov 08, 2022$8.9 (+25.35%)Earnings
- Q2 2022 Neogenomics Inc Earnings Call TranscriptAug 09, 2022$11.68 (+14.17%)Earnings
- Neogenomics Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Neogenomics Inc Earnings Call TranscriptApr 27, 2022$10.44 (-3.78%)Earnings
- Neogenomics Inc at Raymond James Institutional Investors Conference TranscriptMar 07, 2022
- Q4 2021 Neogenomics Inc Earnings Call TranscriptFeb 23, 2022$18.52 (-1.07%)Earnings
- Q3 2021 Neogenomics Inc Earnings Call TranscriptNov 04, 2021$38.35 (-17.58%)Earnings
- Q2 2021 Neogenomics Inc Earnings Call TranscriptAug 06, 2021$46.75 (-2.01%)Earnings
- Neogenomics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Neogenomics Inc Annual Shareholders Meeting TranscriptMay 27, 2021
- Q1 2021 Neogenomics Inc Earnings and to Discuss Acquisition of Inivata Ltd Call TranscriptMay 05, 2021
- Q4 2020 Neogenomics Inc Earnings Call TranscriptFeb 24, 2021$54.34 (+2.55%)Earnings
- Neogenomics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 Neogenomics Inc Earnings Call TranscriptOct 27, 2020$41.25 (-1.67%)Earnings
- Neogenomics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Neogenomics Inc Earnings Call TranscriptJul 28, 2020$35.8 (-2.77%)Earnings
- Neogenomics Inc Annual Shareholders Meeting TranscriptMay 28, 2020
- Q1 2020 Neogenomics Inc Earnings Call TranscriptApr 28, 2020$27.97 (-7.63%)Earnings
- Q4 2019 Neogenomics Inc Earnings Call TranscriptFeb 27, 2020$27.51 (-8.27%)Earnings
- Q3 2019 Neogenomics Inc Earnings Call TranscriptOct 29, 2019$23.36 (+11.98%)Earnings
- Neogenomics Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q2 2019 Neogenomics Inc Earnings Call TranscriptJul 30, 2019$23.9 (-1.65%)Earnings
- Q1 2019 Neogenomics Inc Earnings Call TranscriptApr 30, 2019$20.83 (-0.29%)Earnings
- Neogenomics Inc at Cowen Health Care Conference TranscriptMar 12, 2019
- Q4 2018 Neogenomics Inc Earnings Call TranscriptFeb 19, 2019Earnings
Neogenomics Inc at Cowen Health Care Conference Transcript
Well, thank you guys for your patience, I really appreciate it. And we're excited to be here to get to tell you a little bit about Neo. My plan is to talk for 15, maybe 20 minutes and then we will take some Q&A. So if you have any questions feel free to let us know.
This is a longer deck than what we had, so I'm going to quickly move through some pages. If there is anything that looks interesting and you want me to stop, feel free to ask questions. Forward-looking statements.
All right, so let me just talk here for a few minutes and just keep this a little bit easy. Before I come to this slide let me tell you a little bit about Neo. Neo started in 2002 with our first CLIA accredited lab. And in 2008 we were at about $20 million of revenue. And then fast-forward 10 years, we finished last year with $272 million in revenue.
So we are a growth story for sure. We went through organic growth all the way up to 2015, 2016 and we made a major acquisition of Clarient out of GE. And so, was the legacy Neo business coupled with Clarient.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)